-
Liothyronine Sodium
- names:
三碘甲状腺原氨酸钠; 三碘甲腺原氨酸钠; 碘塞罗宁钠; 碘甲腺氨酸钠; 三碘甲状腺氨酸钠
- CAS号:
1955-6-1
MDL Number: - MF(分子式): C15H11I3NNaO4 MW(分子量): 672.96
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|
| 中文别名 | Liothyronine Sodium |
| 英文别名 | Liothyronine; Triiodothyronine; 3,3',5-Triiodo-L-thyronine; Liothyronin; Tresitope; 3,5,3'-triiodothyronine; Cytomel; Tertroxin |
| CAS号 | 1955-6-1 |
| Inchi | InChI=1S/C15H12I3NO4.Na/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22;/h1-4,6,12,20H,5,19H2,(H,21,22);/q;+1/p-1/t12-;/m0./s1 |
| InchiKey | SBXXSUDPJJJJLC-YDALLXLXSA-M |
| 分子式 Formula | C15H11I3NNaO4 |
| 分子量 Molecular Weight | 672.96 |
| 溶解度Solubility | |
| 性状 | White to off-white solid powder. |
| 储藏条件 Storage conditions | Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years). |
| 产品说明 | Liothyronine Sodium(CAS:1955-6-1):仅限应用于工业或者科学研究过程中非医疗目的,不应用于人类或动物的临床诊断以及治过程疗,该产品非药用,非食用。 |
| Introduction | Liothyronine is a synthetic form of thyroid hormone (T3) used to treat hypothyroidism and myxedema coma. It is also used as an augmentation strategy in treating Major Depressive Disorder when used in combination with antidepressants. It is marketed as the sodium salt under the brand name Cytomel (or Tertroxin in Australia). |
| Application1 | |
| Application2 | |
| Application3 |
| [1]Jonklaas J, Burman KD. Daily Administration of Short-Acting Liothyronine Is Associated with Significant Triiodothyronine Excursions and Fails to Alter Thyroid-Responsive Parameters. Thyroid. 2016 Apr 28. [Epub ahead of print] PubMed PMID: 27030088. |
| [2]Trimboli P, Centanni M, Virili C. Liquid liothyronine to obtain target TSH in differentiated thyroid cancer patients. Endocr J. 2016 Mar 18. [Epub ahead of print] PubMed PMID: 27000530. |
| [3] Leese GP, Soto-Pedre E, Donnelly LA. Liothyronine use in a 17 year observational population-based study - The tears study. Clin Endocrinol (Oxf). 2016 Mar 4. doi: 10.1111/cen.13052. [Epub ahead of print] PubMed PMID: 26940864. |
| [4] Maruo Y, Mori A, Morioka Y, Sawai C, Mimura Y, Matui K, Takeuchi Y. Successful every-other-day liothyronine therapy for severe resistance to thyroid hormone beta with a novel THRB mutation; case report. BMC Endocr Disord. 2016 Jan 12;1 |
| 6:1. doi: 10.1186/s12902-015-0081-7. PubMed PMID: 26754848; PubMed Central PMCID: PMC4709977. |
5: Foeller ME, Silver RM. Combination Levothyroxine + Liothyronine Treatment in Pregnancy. Obstet Gynecol Surv. 2015 Sep;70(9):584-6. doi: 10.1097/OGX.0000000000000217. PubMed PMID: 26403562.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


